Mesh : Cognitive Dysfunction / etiology Dementia, Vascular / complications drug therapy genetics Donepezil / administration & dosage Humans Male Memantine / administration & dosage Middle Aged Mutation Nootropic Agents / administration & dosage Receptor, Notch3 White Matter / diagnostic imaging pathology

来  源:   DOI:10.1097/MD.0000000000016920   PDF(Sci-hub)   PDF(Pubmed)

Abstract:
BACKGROUND: Vascular cognitive impairment (VCI) is a common cause of dementia. Research suggests that hereditary factors (gene mutations) play an important role in the pathogenesis of VCI, and a mutation of the NOTCH3 locus is frequently identified in affected patients. Herein, we report the case of a patient with confirmed VCI associated with a NOTCH3 exon 33 gene mutation and review the relevant VCI literature.
UNASSIGNED: A 48-year-old man presented to our neurology clinic with gradually progressive cognitive impairment.
UNASSIGNED: Brain magnetic resonance imaging revealed multiple punctate hyperintensities in the patient\'s periventricular white matter. Genetic analysis showed a c.6744C > T, p. Ala2223Val substitution in exon 33 of the NOTCH3 gene. We diagnosed thepatient with VCI secondary to a NOTCH3 gene mutation.
METHODS: Donepezil (5 mg) and memantine (5 mg) daily.
RESULTS: The patient showed symptom improvement at his 3-month and 6-month follow-up appointments.
CONCLUSIONS: This patient may have a new type of mutation that is different from the one seen in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, although it involves a NOTCH3 defect. We propose that the entire NOTCH3 gene should be sequenced in patients with suspected hereditary VCI. This practice could facilitate the discovery of newpathogenic mutations and diseases.
摘要:
暂无翻译
公众号